Free Trial

Bausch + Lomb (BLCO) Competitors

Bausch + Lomb logo
$14.06 -0.19 (-1.30%)
Closing price 03:59 PM Eastern
Extended Trading
$13.85 -0.21 (-1.46%)
As of 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BLCO vs. ZBH, SNN, SOLV, PEN, STVN, GKOS, IRTC, SLNO, TMDX, and INSP

Should you be buying Bausch + Lomb stock or one of its competitors? The main competitors of Bausch + Lomb include Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

Bausch + Lomb vs. Its Competitors

Bausch + Lomb (NYSE:BLCO) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

In the previous week, Zimmer Biomet had 3 more articles in the media than Bausch + Lomb. MarketBeat recorded 8 mentions for Zimmer Biomet and 5 mentions for Bausch + Lomb. Zimmer Biomet's average media sentiment score of 0.69 beat Bausch + Lomb's score of 0.58 indicating that Zimmer Biomet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Zimmer Biomet
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Zimmer Biomet has higher revenue and earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$4.79B1.04-$317M-$1.03-13.65
Zimmer Biomet$7.68B2.50$903.70M$4.5221.43

Bausch + Lomb currently has a consensus target price of $15.45, suggesting a potential upside of 9.96%. Zimmer Biomet has a consensus target price of $111.39, suggesting a potential upside of 15.01%. Given Zimmer Biomet's stronger consensus rating and higher probable upside, analysts clearly believe Zimmer Biomet is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17
Zimmer Biomet
2 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.35

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are held by institutional investors. 0.8% of Bausch + Lomb shares are held by company insiders. Comparatively, 1.4% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Zimmer Biomet has a net margin of 11.86% compared to Bausch + Lomb's net margin of -7.50%. Zimmer Biomet's return on equity of 12.73% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-7.50% 2.62% 1.28%
Zimmer Biomet 11.86%12.73%7.34%

Bausch + Lomb has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500.

Summary

Zimmer Biomet beats Bausch + Lomb on 16 of the 16 factors compared between the two stocks.

Get Bausch + Lomb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLCO vs. The Competition

MetricBausch + LombMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$4.97B$7.21B$5.67B$21.05B
Dividend YieldN/A2.80%4.05%3.62%
P/E Ratio-13.6525.2227.9227.79
Price / Sales1.0440.06397.1871.63
Price / Cash7.6427.1236.1922.61
Price / Book0.769.738.634.67
Net Income-$317M$239.98M$3.24B$993.85M
7 Day Performance-0.90%1.47%3.17%1.16%
1 Month Performance16.44%5.62%10.73%4.99%
1 Year Performance-13.08%17.98%35.04%12.52%

Bausch + Lomb Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLCO
Bausch + Lomb
2.1916 of 5 stars
$14.06
-1.3%
$15.45
+10.0%
-16.3%$4.97B$4.79B-13.6513,500News Coverage
Upcoming Earnings
ZBH
Zimmer Biomet
4.9136 of 5 stars
$93.79
flat
$110.00
+17.3%
-11.5%$18.56B$7.68B20.7517,000
SNN
Smith & Nephew SNATS
2.8059 of 5 stars
$30.06
-0.7%
$28.00
-6.8%
+11.6%$13.16B$5.81B13.9117,349
SOLV
Solventum
0.9679 of 5 stars
$74.08
+0.4%
$81.50
+10.0%
+31.4%$12.82B$8.25B34.3022,000Positive News
PEN
Penumbra
4.608 of 5 stars
$238.82
+0.4%
$305.07
+27.7%
+24.2%$9.25B$1.24B225.314,500Positive News
Upcoming Earnings
STVN
Stevanato Group
1.5797 of 5 stars
€25.55
+1.3%
N/A+18.1%€7.74B€1.12B50.105,521Gap Up
GKOS
Glaukos
4.4622 of 5 stars
$104.43
+0.6%
$134.67
+29.0%
-23.4%$5.97B$404.52M-44.06780Positive News
Upcoming Earnings
IRTC
iRhythm Technologies
1.2872 of 5 stars
$138.91
+2.2%
$138.60
-0.2%
+34.4%$4.43B$591.84M-44.242,000Positive News
Upcoming Earnings
SLNO
Soleno Therapeutics
3.7909 of 5 stars
$82.76
+1.5%
$108.70
+31.3%
+80.7%$4.17BN/A-17.9130Positive News
TMDX
TransMedics Group
2.3545 of 5 stars
$116.88
+3.9%
$127.33
+8.9%
-29.2%$3.95B$441.54M85.94210Positive News
Upcoming Earnings
INSP
Inspire Medical Systems
4.9082 of 5 stars
$130.17
-0.1%
$211.91
+62.8%
-5.3%$3.84B$802.80M59.981,246Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:BLCO) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners